NovoCure (NVCR) Tax Rate Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116.00 |
| Dec 31, 2025 | 5,475.00 |
| Sep 30, 2025 | -1,065.00 |
| Jun 30, 2025 | -1,196.00 |
| Mar 31, 2025 | 7,149.00 |
| Dec 31, 2024 | -1,595.00 |
| Sep 30, 2024 | -1,703.00 |
| Jun 30, 2024 | -3,622.00 |
| Mar 31, 2024 | 2,849.00 |
| Dec 31, 2023 | -6,646.00 |
| Sep 30, 2023 | -1,852.00 |
| Jun 30, 2023 | -6,566.00 |
| Mar 31, 2023 | -17,186.00 |
| Dec 31, 2022 | -38,216.00 |
| Sep 30, 2022 | 3,497.00 |
| Jun 30, 2022 | 285,070.00 |
| Mar 31, 2022 | -4,164.00 |
| Dec 31, 2021 | 4,095.00 |
| Sep 30, 2021 | 2,840.00 |
| Jun 30, 2021 | 4,533.00 |
| Mar 31, 2021 | -3,277.00 |
| Dec 31, 2020 | 10,314.00 |
| Sep 30, 2020 | 5,829.00 |
| Jun 30, 2020 | 7,869.00 |
| Mar 31, 2020 | 18,206.00 |
| Dec 31, 2019 | 36,523.00 |
| Sep 30, 2019 | -3,804.00 |
| Jun 30, 2019 | -284,603.00 |
| Mar 31, 2019 | -3,405.00 |
| Dec 31, 2018 | -3,981.00 |
| Sep 30, 2018 | -4,911.00 |
| Jun 30, 2018 | -5,142.00 |
| Mar 31, 2018 | -1,495.00 |
| Dec 31, 2017 | -5,844.00 |
| Sep 30, 2017 | -4,037.00 |